Roles for NF-κB and c-Fos in osteoclasts

被引:86
作者
Boyce, BF [1 ]
Yamashita, T [1 ]
Yao, ZQ [1 ]
Zhang, Q [1 ]
Li, F [1 ]
Xing, LP [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
关键词
osteoclasts; osteoblasts; apoptosis; regulation;
D O I
10.1007/BF03026317
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
NF-kappa B and c-Fos are transcription factors that are activated in immune cells and in most other cell types following stimulation by a variety of factors, including cytokines. growth factors. and hormones. They regulate the expression of a large number of genes, and both are activated in osteoclast precursors after RANKL, IL-1, or TNF bind to their respective receptors. However, of these cytokines. only RANKL is required for the induction of osteoclast formation in vivo. Nevertheless, it is likely that IL-1, TNF, and other cytokines participate in the upregulation of osteoclast formation seen in a variety of conditions that affect the skeleton in which cytokine production is increased, including estrogen deficiency and inflammatory bone diseases. In this review, the RANKL/ OPG/RANK system and roles for NF-kappa B and c-Fos in osteoclasts are reviewed along with our current understanding of how this system may be disrupted in common bone diseases, Such as postmenopausal osteoporosis, inflammatory arthritis. and Paget's disease.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 62 条
[31]
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand [J].
Kong, YY ;
Feïge, U ;
Sarosi, I ;
Bolon, B ;
Tafuri, A ;
Morony, S ;
Capparelli, C ;
Li, J ;
Elliott, R ;
McCabe, S ;
Wong, T ;
Campagnuolo, G ;
Moran, E ;
Bogoch, ER ;
Van, G ;
Nguyen, LT ;
Ohashi, PS ;
Lacey, DL ;
Fish, E ;
Boyle, WJ ;
Penninger, JM .
NATURE, 1999, 402 (6759) :304-309
[32]
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis [J].
Kong, YY ;
Yoshida, H ;
Sarosi, I ;
Tan, HL ;
Timms, E ;
Capparelli, C ;
Morony, S ;
Oliveira-dos-Santos, AJ ;
Van, G ;
Itie, A ;
Khoo, W ;
Wakeham, A ;
Dunstan, CR ;
Lacey, DL ;
Mak, TW ;
Boyle, WJ ;
Penninger, JM .
NATURE, 1999, 397 (6717) :315-323
[33]
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation [J].
Lacey, DL ;
Timms, E ;
Tan, HL ;
Kelley, MJ ;
Dunstan, CR ;
Burgess, T ;
Elliott, R ;
Colombero, A ;
Elliott, G ;
Scully, S ;
Hsu, H ;
Sullivan, J ;
Hawkins, N ;
Davy, E ;
Capparelli, C ;
Eli, A ;
Qian, YX ;
Kaufman, S ;
Sarosi, I ;
Shalhoub, V ;
Senaldi, G ;
Guo, J ;
Delaney, J ;
Boyle, WJ .
CELL, 1998, 93 (02) :165-176
[34]
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism [J].
Li, J ;
Sarosi, I ;
Yan, XQ ;
Morony, S ;
Capparelli, C ;
Tan, HL ;
McCabe, S ;
Elliott, R ;
Scully, S ;
Van, G ;
Kaufman, S ;
Juan, SC ;
Sun, Y ;
Tarpley, J ;
Martin, L ;
Christensen, K ;
McCabe, J ;
Kostenuik, P ;
Hsu, H ;
Fletcher, F ;
Dunstan, CR ;
Lacey, DL ;
Boyle, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1566-1571
[35]
RANK signaling is not required for TNFα-mediated increase in CD11bhi osteoclast precursors but is essential for mature osteoclast formation in TNFα-mediated inflammatory arthritis [J].
Li, P ;
Schwarz, EM ;
O'Keefe, RJ ;
Ma, L ;
Boyce, BF ;
Xing, LP .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (02) :207-213
[36]
Systemic tumor necrosis factor α mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor α-transgenic mice [J].
Li, P ;
Schwarz, EM ;
O'Keefe, RJ ;
Ma, L ;
Looney, RJ ;
Ritchlin, CT ;
Boyce, BF ;
Xing, LP .
ARTHRITIS AND RHEUMATISM, 2004, 50 (01) :265-276
[37]
Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone [J].
Locklin, RM ;
Khosla, S ;
Turner, RT ;
Riggs, BL .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (01) :180-190
[38]
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos [J].
Matsuo, K ;
Galson, DL ;
Zhao, C ;
Peng, L ;
Laplace, C ;
Wang, KZQ ;
Bachler, MA ;
Amano, H ;
Aburatani, H ;
Ishikawa, H ;
Wagner, EF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (25) :26475-26480
[39]
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability [J].
McGill, GG ;
Horstmann, M ;
Widlund, HR ;
Du, JY ;
Motyckova, G ;
Nishimura, EK ;
Lin, YL ;
Ramaswamy, S ;
Avery, W ;
Ding, HF ;
Jordan, SA ;
Jackson, IJ ;
Korsmeyer, SJ ;
Golub, TR ;
Fisher, DE .
CELL, 2002, 109 (06) :707-718
[40]
Reciprocal role of ERK and NF-κB pathways in survival and activation of osteoclasts [J].
Miyazaki, T ;
Katagiri, H ;
Kanegae, Y ;
Takayanagi, H ;
Sawada, Y ;
Yamamoto, A ;
Pando, MP ;
Asano, T ;
Verma, IM ;
Oda, H ;
Nakamura, K ;
Tanaka, S .
JOURNAL OF CELL BIOLOGY, 2000, 148 (02) :333-342